AstraZeneca 'Very Comfortable' With COVID-19 Vaccine's Effectiveness In Preventing Severe Disease: Exec
U.K.-based AstraZeneca plc (NASDAQ: AZN) has already administered millions of doses of its COVID-19 vaccine in its home country and is now ready to file for emergency use authorization in the U.S., AstraZeneca U.S.
